MOLECULAR PATHOLOGY LABORATORY NETWORK INC NPI 1053335729

NPI Details

MOLECULAR PATHOLOGY LABORATORY NETWORK INC is a clinical medical laboratory in Maryville, TN. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. MOLECULAR PATHOLOGY LABORATORY NETWORK INC NPI is 1053335729. The provider is registered as an organization entity type.
The provider Other Name Is Ascendant Medical Laboratory.

The provider's business location address is:

250 E BROADWAY AVE
MARYVILLE, TN
ZIP 37804-782
Phone: (865) 380-9746
Fax: (865) 273-1129

The provider's authorized official is Roger Allan Hubbard .
The authorized official title is Owner, Ceo and has the following contact phone number (865) 380-9746.

The CLIA number assigned to this NPI record is 44D0948725 - independent with a certificate type of Certificate of Accreditation.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure (HCPCS:88374)
• Special stained specimen slides to examine tissue including interpretation and report (HCPCS:88313)
• Flow cytometry technique for dna or cell analysis, 16 or more markers (HCPCS:88189)
• Special stained specimen slides to examine tissue, each additional procedure (HCPCS:88341)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
• Preparation of tissue for examination by removing any calcium present (HCPCS:88311)
• Bone marrow, smear interpretation (HCPCS:85097)
• Special stained specimen slides to examine tissue, initial procedure (HCPCS:88342)
• Tissue culture for tumor disorders of bone marrow and blood cells (HCPCS:88237)
• Chromosome analysis for genetic defects, analyze 20-25 cells (HCPCS:88264)
• Interpretation and report of genetic testing (HCPCS:88291)
• Detection test by nucleic acid for human papillomavirus (hpv), high-risk types (HCPCS:87624)
• Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure (HCPCS:88377)
• Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure (HCPCS:88374)
• Test for detecting genes associated with blood related cancer (HCPCS:81450)
• Flow cytometry technique for dna or cell analysis, 16 or more markers (HCPCS:88189)
• Interpretation and report of genetic testing (HCPCS:88291)
• Gene analysis (tumor protein 53) full sequence analysis (HCPCS:81351)
• Gene rearrangement analysis (immunoglobulin heavy chain locus), variable region somatic mutation analysis (HCPCS:81263)
• Flow cytometry technique for dna or cell analysis, 2 to 8 markers (HCPCS:88187)
• Cell examination of urine, manual (HCPCS:88120)
• Detection test by nucleic acid for human papillomavirus (hpv), types 16 and 18 only (HCPCS:87625)
• Genetic sequencing localization, each additional procedure (HCPCS:88364)
• Genetic sequencing localization, initial procedure (HCPCS:88365)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test (HCPCS:G0476)
• Gene analysis (myeloid differentiation primary response 88) for p.leu265pro variant (HCPCS:81305)
• Chromosome analysis for genetic defects, additional cells counted, each study (HCPCS:88285)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)

The enumeration date for this NPI number is 7/27/2006 and was last updated on 5/3/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.